EGFR-HER2 inhibitor AG-1517, Purity ≥98%

Cat. No.: X24-05-ZQ635

EGFR-HER2 inhibitor AG-1517, Purity ≥98%

Synonym: 153436-54-5; AG1517; AG-1517; EGFR-HER2 inhibitor

  • CAS Number: 153436-54-5
  • Compound CID: 4705
Product Size
5 mg; 10 mg; 25 mg
Price
Datasheet
MSDS
Properties
Description
AG-1517, soluble in DMSO and insoluble in ethanol and water, is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells. It targets EGFR and EGFR.
Molecular Weight
360.2
Molecular Formula
C16H14BrN3O2
Targets
EGFR: 6 pM (Ki); EGFR: 25 pM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 6 mg/mL (16.65 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
AG-1517 is utilized for research on its EGFR tyrosine kinase inhibition and potential anti-cancer activities.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.